One-year healthcare utilization outcomes of two- versus one-injection start regimens of aripiprazole once-monthly in schizophrenia: a retrospective cohort study
The two-injection start (TIS) regimen of aripiprazole once-monthly (AOM) avoids the 14-day oral supplementation required with the one-injection start (OIS), but real-world evidence comparing their longer-term healthcare utilization outcomes in acutely hospitalized patients with schizophrenia remains limited. We retrospectively compared 131 patients hospitalized for an acute psychotic exacerbation of schizophrenia who initiated AOM via OIS ( n = 79) or TIS ( n = 52). Primary outcomes were time to first psychiatric rehospitalization and emergency room (ER) visit within 1 year. Analyses included Kaplan–Meier estimates, Cox models adjusted for age, sex, and baseline chlorpromazine-equivalent dose, supplementary stabilized inverse probability of treatment weighting (IPTW) Cox models with robust variance estimation, and marginally standardized risk differences with bootstrap confidence intervals. At 1 year, rehospitalization rates were 44.3% with OIS and 32.7% with TIS (log-rank p = 0.231); ER visit rates were 55.7% and 38.5%, respectively ( p = 0.105). For rehospitalization and ER visits, respectively, adjusted Cox hazard ratios (HRs) were 0.57 (95% CI 0.30–1.07; p = 0.081) and 0.58 (95% CI 0.33–1.01; p = 0.054), while IPTW HRs were 0.63 (0.35–1.15; p = 0.134) and 0.59 (0.33–1.03; p = 0.065). Adjusted risk differences (TIS minus OIS) were − 15.5% points (95% CI − 32.3 to 2.8) for rehospitalization and − 17.5 points (− 34.3 to 1.1) for ER visits. Although estimates numerically favored TIS, all comparisons remained statistically nonsignificant. Given the modest sample and potential residual confounding, findings are hypothesis-generating and require confirmation in larger prospective multicenter studies.
Authors
- Mustafa Kurt (ORCID: https://orcid.org/0000-0002-2666-7087)
- Ali Taşdemir (ORCID: https://orcid.org/0000-0001-5014-9725)
Institutions
- Karadeniz Technical University (TR)
Publication Details
- Journal
- BMC Psychiatry
- Published
- 2026-11-18
- DOI
- https://doi.org/10.1186/s12888-026-08870-9
- Primary Topic
- Schizophrenia research and treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00